BIIB

Biogen

Health Care

Biotechnology

Cambridge, Massachusetts

Balance Sheet 32 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$2.4B	$1.0B	$3.4B	$2.3B	$1.3B
Assets - MarketableSecuritiesCurrent	$179.7M	$0	$1.5B	$1.5B	$1.3B
Assets - AccountsReceivable	$1.4B	$1.7B	$1.7B	$1.5B	$1.9B
Assets - Inventories	$2.5B	$2.5B	$1.3B	$1.4B	$1.1B
Assets - PrepaidExpensesAndOtherCurrentAssets	$752.5M	$1.2B	$1.4B	$740.8M	$881.1M
Assets - TotalCurrentAssets	$7.5B	$6.9B	$9.8B	$7.9B	$6.9B
Assets - Property,PlantAndEquipment	$3.2B	$3.3B	$3.3B	$3.4B	$3.4B
Assets - Goodwill	$6.5B	$6.2B	$5.7B	$5.8B	$5.8B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$9.7B	$8.4B	$1.9B	$2.2B	$3.1B
Assets - DeferredTaxAssets	$2.9B	$2.9B	$2.6B	$2.5B	$2.3B
Assets - OperatingLeaseAssets	$356.4M	$420.0M	$403.9M	$375.4M	$433.3M
Assets - OtherNoncurrentAssets	$560.5M	$745.0M	$1.5B	$1.9B	$2.9B
Assets - TotalAssets	$28.0B	$26.8B	$24.6B	$23.9B	$24.6B
Liabilities - AccountsPayable	$424.2M	$403.3M	$491.5M	$589.2M	$454.9M
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$1.7B	$150.0M	$0	$999.1M	$0
Liabilities - ContingentConsiderationLiabilityCurrent	$291.2M	$0	—	—	$149.6M
Liabilities - OtherCurrentLiabilities	$2.8B	$2.6B	$2.5B	$2.5B	$3.1B
Liabilities - TotalCurrentLiabilities	$5.5B	$3.4B	$3.3B	$4.3B	$3.7B
Liabilities - LongTermDebt	$6.3B	$6.8B	$6.3B	$6.3B	$7.4B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$334.5M	$400.0M	$333.0M	$330.4M	$402.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$190.5M	$641.8M	$334.7M	$694.5M	$1.0B
Liabilities - ContingentConsiderationLiabilityNoncurrent	$221.6M	—	—	$209.1M	$110.3M
Liabilities - OtherNoncurrentLiabilities	$732.3M	$781.1M	$944.2M	$1.3B	$1.3B
Liabilities - TotalLiabilities	$11.3B	$12.0B	$11.2B	$12.9B	$13.9B
Equity - PreferredStock	$8.0M	$0	$0	$0	$0
Equity - CommonStock	$1.3B	$100.0K	$100.0K	$100.0K	$100.0K
Equity - AdditionalPaidInCapital	$569.4M	$302.5M	$73.3M	$68.2M	$0
Equity - RetainedEarnings(deficit)	$19.3B	$17.6B	$16.5B	$13.9B	$14.0B
Equity - TreasuryStock	$3.0B	$3.0B	$3.0B	$3.0B	$3.0B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-136.2M	$-153.7M	$-164.9M	$-106.7M	$-299.0M
Equity - TotalLiabilitiesAndStockholdersEquity	$28.0B	$26.8B	$24.6B	$23.9B	$24.6B

Income Statement 23 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetRevenues/ProductSales	$9.7B	$9.8B	$10.2B	$11.0B	$13.4B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold/CostOfSales	$2.3B	$2.5B	$2.3B	$2.1B	$1.8B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$2.0B	$2.5B	$2.2B	$2.5B	$4.0B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative	$2.4B	$2.5B	$2.4B	$2.7B	$2.5B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$386.5M	$240.6M	$246.3M	$252.0M	$255.1M
IncomeStatement - CostsAndExpenses - ImpairmentCharges(operating)	$60.2M	$0	$119.6M	$629.3M	$209.7M
IncomeStatement - CostsAndExpenses - RestructuringCharges	$30.2M	$218.8M	$131.1M	$0	$0
IncomeStatement - OtherIncomeExpense - InterestExpense	$250.3M	$246.9M	$246.6M	$253.6M	$222.5M
IncomeStatement - OtherIncomeExpense - InterestIncome	$67.6M	$276.5M	$89.3M	$11.0M	$42.0M
IncomeStatement - OtherIncomeExpense - Gain(loss)OnInvestments/securities	$100.4M	$275.2M	$264.7M	$821.1M	$-693.9M
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$29.6M	$3.5M	$10.1M	$5.6M	$-2.9M
IncomeStatement - OtherIncomeExpense - Income(loss)BeforeIncomeTaxes	$1.9B	$1.3B	$3.6B	$1.7B	$5.0B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$273.8M	$135.3M	$632.8M	$52.5M	$992.3M
IncomeStatement - IncomeTax - EffectiveTaxRate	$0	$0	$0	$0	$0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$1.6B	$1.2B	$3.0B	$1.6B	$4.0B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToNoncontrollingInterest	$0	$400.0K	$-85.3M	$171.5M	$59.9M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$1.6B	$1.2B	$3.0B	$1.6B	$4.0B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$11	$8	$21	$10	$25
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$11	$8	$21	$10	$25
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$145.6M	$144.7M	$145.3M	$149.1M	$160.9M
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$145.9M	$145.6M	$146.0M	$149.6M	$161.3M
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$1.6B	$1.2B	$3.0B	$1.7B	$3.8B

Cash Flow Statement 27 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$1.6B	$1.2B	$3.0B	$1.6B	$4.0B
CashFlow - OperatingActivities - DepreciationAndAmortization	$673.2M	$494.8M	$518.4M	$487.7M	$457.2M
CashFlow - OperatingActivities - ShareBasedCompensation	$291.2M	$264.2M	$254.1M	$238.6M	$198.3M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-158.1M	$-305.8M	$-168.6M	$-426.8M	$149.0M
CashFlow - OperatingActivities - Gain/lossOnSaleOfAssets/investments	$100.4M	$291.2M	$277.3M	$824.9M	$-685.7M
CashFlow - OperatingActivities - ImpairmentCharges(nonCash)	$60.2M	$0	$119.6M	$629.3M	$209.7M
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$28.1M	$4.6M	$19.0M	$-1.2M	$-176.7M
CashFlow - OperatingActivities - NetCashFromOperatingActivities	$2.9B	$1.5B	$1.4B	$3.6B	$4.2B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e)	$153.7M	$277.0M	$240.3M	$258.1M	$424.8M
CashFlow - InvestingActivities - PurchasesOfMarketableSecurities/investments	$0	$5.1B	$3.4B	$3.8B	$6.4B
CashFlow - InvestingActivities - ProceedsFromSales/maturitiesOfMarketableSecurities/investments	$0	$7.4B	$3.7B	$3.4B	$7.3B
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$1.1B	$6.9B	$-582.6M	$0	$0
CashFlow - InvestingActivities - PaymentsToAcquireIntangibleAssets	$206.1M	$34.4M	$2.9M	$18.8M	$52.0M
CashFlow - InvestingActivities - ProceedsFromSaleOfProperty,PlantAndEquipment	$88.6M	$0	$0	$28.1M	$0
CashFlow - InvestingActivities - OtherInvestingActivities	$4.7M	$11.3M	$-24.4M	$-12.9M	$26.9M
CashFlow - InvestingActivities - NetCashFromInvestingActivities	$-799.2M	$-4.1B	$1.6B	$-563.7M	$-608.6M
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$0	$997.2M	$0	$0	$3.0B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$0	$0	$750.0M	$1.8B	$6.7B
CashFlow - FinancingActivities - PaymentsRelatedToTaxWithholdingForShareBasedCompensation	$31.3M	$44.3M	$1.9M	$700.0K	$4.6M
CashFlow - FinancingActivities - OtherFinancingActivities	$-2.2M	$-6.0M	$-5.6M	$-21.1M	$14.6M
CashFlow - FinancingActivities - NetCashFromFinancingActivities	$-683.5M	$149.3M	$-1.7B	$-2.1B	$-5.3B
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-67.7M	$35.1M	$-55.7M	$-59.8M	$69.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$1.4B	$-2.4B	$1.2B	$990.0M	$-1.7B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$355.1M	$740.7M	$932.9M	$247.9M	$906.7M
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$245.4M	$252.2M	$262.5M	$280.8M	$272.7M
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$16.9M	$146.0M	$108.3M	$18.1M	$59.0M

Biogen

Balance Sheet 32 Accounts • 5 Years

Income Statement 23 Accounts • 5 Years

Cash Flow Statement 27 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History